Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The Other Vaccines market in CIS is showing positive growth in recent years, with increasing demand from customers and favorable market conditions.
Customer preferences: Customers in CIS are increasingly aware of the importance of vaccination and are seeking out other vaccines beyond the standard ones. This is due to the increasing prevalence of diseases such as meningitis, which has raised awareness of the need for preventative measures. Additionally, the COVID-19 pandemic has also increased demand for vaccinations in general, which has spilled over into the Other Vaccines market.
Trends in the market: The Other Vaccines market in CIS is experiencing growth due to several factors. Firstly, there is increasing government support for vaccination programs, which has led to greater accessibility and affordability of vaccines. Secondly, there is a growing trend towards medical tourism, with many patients from neighboring countries coming to CIS for medical treatments, including vaccinations. Finally, there is a growing trend towards preventative healthcare, with many individuals seeking out vaccinations as a way to maintain good health.
Local special circumstances: CIS is a region with a unique set of circumstances that impact the Other Vaccines market. Firstly, there is a lack of awareness and education about the importance of vaccination, which has hindered growth in the past. However, this is changing as governments and healthcare providers are investing in education and awareness campaigns. Secondly, there are significant differences in healthcare infrastructure and access to medical facilities across the region, which has led to disparities in vaccination rates. Finally, there are cultural and religious factors that impact vaccination rates, with some groups being more hesitant to vaccinate than others.
Underlying macroeconomic factors: The Other Vaccines market in CIS is also impacted by broader macroeconomic factors. Firstly, there is a growing middle class in the region, which has led to increased demand for healthcare services, including vaccinations. Secondly, there is a growing trend towards privatization of healthcare services, which has led to greater competition and innovation in the market. Finally, there is a growing focus on healthcare as a key driver of economic growth, which has led to greater investment in the sector.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
